SARS-CoV-2 Inactivated Vaccine (Beijing Kexing Zhongwei Biotech)

新型冠状病毒灭活疫苗（Vero细胞）（科兴中维）

Report date: 2022/08/08 11:24:17

Base Information

Drug NameSARS-CoV-2 Inactivated Vaccine (Beijing Kexing Zhongwei Biotech)
Drug Alias NameAdsorbed COVID-19 (inactivated) Vaccine (Sinovac Biotech)COVID-19 Vaccine (Vero Cell), Inactivated (Beijing Kexing Zhongwei Biotech)克尔来福CoronaVac
ClassificationVaccines > Development/production technology > Inactivated vaccine > Whole microorganism inactivated vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Influenza B virus infection
Global Approved IndicationsCoronavirus Disease 2019 (COVID-19)
Approved Indications in ChinaCoronavirus Disease 2019 (COVID-19)
Original Approved Country/TerritoryMainland China
Original Approved Date2021/02/05
Country/TerritoryTunisiaPhilippinesTurkey +[12] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSinovac Life Sciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSinovac Research And Development Co LtdSinovac Biotech (Colombia) SASPontificia Universidad Catolica De Chile +[9] 
Inactive CompaniesSinovac Biotech (Hong Kong) LtdSinoCelltech Ltd
Active IndicationsCoronavirus Disease 2019 (COVID-19)Influenza B virus infection
Inactive IndicationsN/A

Other Information

ATC CodeJ07B
Related LinksN/A